Minerva Surgical Statistics
Total Valuation
UTRS has a market cap or net worth of 888. The enterprise value is 32.43 million.
| Market Cap | 888 |
| Enterprise Value | 32.43M |
Important Dates
The last earnings date was Friday, March 7, 2025.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTRS has 8.88 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 8.88M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.97 |
| EV / Sales | 0.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.84 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 2.15.
| Current Ratio | 1.88 |
| Quick Ratio | 0.88 |
| Debt / Equity | 2.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.12 |
| Interest Coverage | -7.79 |
Financial Efficiency
Return on equity (ROE) is -160.07% and return on invested capital (ROIC) is -34.21%.
| Return on Equity (ROE) | -160.07% |
| Return on Assets (ROA) | -27.35% |
| Return on Invested Capital (ROIC) | -34.21% |
| Return on Capital Employed (ROCE) | -66.47% |
| Revenue Per Employee | 297,086 |
| Profits Per Employee | -192,241 |
| Employee Count | 174 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.98% in the last 52 weeks. The beta is 35.28, so UTRS's price volatility has been higher than the market average.
| Beta (5Y) | 35.28 |
| 52-Week Price Change | -99.98% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 18.55 |
| Average Volume (20 Days) | 5,762 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.16 |
Income Statement
In the last 12 months, UTRS had revenue of 51.69 million and -33.45 million in losses. Loss per share was -5.38.
| Revenue | 51.69M |
| Gross Profit | 28.01M |
| Operating Income | -34.26M |
| Pretax Income | -33.40M |
| Net Income | -33.45M |
| EBITDA | -25.56M |
| EBIT | -34.26M |
| Loss Per Share | -5.38 |
Balance Sheet
The company has 11.13 million in cash and 43.55 million in debt, giving a net cash position of -32.43 million or -3.65 per share.
| Cash & Cash Equivalents | 11.13M |
| Total Debt | 43.55M |
| Net Cash | -32.43M |
| Net Cash Per Share | -3.65 |
| Equity (Book Value) | 20.26M |
| Book Value Per Share | 2.28 |
| Working Capital | 18.75M |
Cash Flow
In the last 12 months, operating cash flow was -38.73 million and capital expenditures -53,000, giving a free cash flow of -38.79 million.
| Operating Cash Flow | -38.73M |
| Capital Expenditures | -53,000 |
| Free Cash Flow | -38.79M |
| FCF Per Share | -4.37 |
Margins
Gross margin is 54.18%, with operating and profit margins of -66.27% and -64.71%.
| Gross Margin | 54.18% |
| Operating Margin | -66.27% |
| Pretax Margin | -64.61% |
| Profit Margin | -64.71% |
| EBITDA Margin | -49.45% |
| EBIT Margin | -66.27% |
| FCF Margin | n/a |
Dividends & Yields
UTRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -363.35% |
| Shareholder Yield | -363.35% |
| Earnings Yield | -3,766,891.89% |
| FCF Yield | -4,367,792.79% |
Stock Splits
The last stock split was on October 2, 2023. It was a reverse split with a ratio of 0.05.
| Last Split Date | Oct 2, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
UTRS has an Altman Z-Score of -6.14. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.14 |
| Piotroski F-Score | n/a |